Literature DB >> 29367462

High self-reactivity drives T-bet and potentiates Treg function in tissue-specific autoimmunity.

Maran L Sprouse1, Marissa A Scavuzzo2, Samuel Blum1, Ivan Shevchenko1, Thomas Lee1, George Makedonas3, Malgorzata Borowiak4,5, Matthew L Bettini1,5, Maria Bettini1,5.   

Abstract

T cell receptor (TCR) affinity is a critical factor of Treg lineage commitment, but whether self-reactivity is a determining factor in peripheral Treg function remains unknown. Here, we report that a high degree of self-reactivity is crucial for tissue-specific Treg function in autoimmunity. Based on high expression of CD5, we identified a subset of self-reactive Tregs expressing elevated levels of T-bet, GITR, CTLA-4, and ICOS, which imparted significant protection from autoimmune diabetes. We observed that T-bet expression in Tregs, necessary for control of Th1 autoimmunity, could be induced in an IFNγ-independent fashion and, unlike in conventional T cells (Tconv), was strongly correlated with the strength of TCR signaling. The level of CD5 similarly identified human Tregs with an increased functional profile, suggesting that CD5hi Tregs may constitute an efficacious subpopulation appropriate for use in adoptive Treg therapies for treatment of inflammatory conditions. Overall, this work establishes an instrumental role of high TCR self-reactivity in driving Treg function.

Entities:  

Keywords:  Autoimmune diseases; Autoimmunity; Diabetes; Immunology; T cells

Mesh:

Substances:

Year:  2018        PMID: 29367462      PMCID: PMC5821181          DOI: 10.1172/jci.insight.97322

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  72 in total

1.  T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development.

Authors:  Naganari Ohkura; Masahide Hamaguchi; Hiromasa Morikawa; Kyoko Sugimura; Atsushi Tanaka; Yoshinaga Ito; Motonao Osaki; Yoshiaki Tanaka; Riu Yamashita; Naoko Nakano; Jochen Huehn; Hans Joerg Fehling; Tim Sparwasser; Kenta Nakai; Shimon Sakaguchi
Journal:  Immunity       Date:  2012-11-01       Impact factor: 31.745

2.  Guanylate binding protein 1-mediated interaction of T cell antigen receptor signaling with the cytoskeleton.

Authors:  Florian Forster; Wolfgang Paster; Verena Supper; Philipp Schatzlmaier; Stefan Sunzenauer; Nicole Ostler; Anna Saliba; Paul Eckerstorfer; Nathalie Britzen-Laurent; Gerhard Schütz; Johannes A Schmid; Gerhard J Zlabinger; Elisabeth Naschberger; Michael Stürzl; Hannes Stockinger
Journal:  J Immunol       Date:  2013-12-13       Impact factor: 5.422

3.  Nuclear receptor Nr4a1 modulates both regulatory T-cell (Treg) differentiation and clonal deletion.

Authors:  Marlys S Fassett; Wenyu Jiang; Anna Morena D'Alise; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-15       Impact factor: 11.205

Review 4.  Once a Treg, always a Treg?

Authors:  Deepali V Sawant; Dario A A Vignali
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

5.  A self-reactive TCR drives the development of Foxp3+ regulatory T cells that prevent autoimmune disease.

Authors:  Justin R Killebrew; Nikole Perdue; Alan Kwan; Angela M Thornton; Ethan M Shevach; Daniel J Campbell
Journal:  J Immunol       Date:  2011-06-20       Impact factor: 5.422

6.  Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis.

Authors:  Duojia Cao; Vivianne Malmström; Clare Baecher-Allan; David Hafler; Lars Klareskog; Christina Trollmo
Journal:  Eur J Immunol       Date:  2003-01       Impact factor: 5.532

7.  Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response.

Authors:  Nan Zhang; Bernd Schröppel; Girdhari Lal; Claudia Jakubzick; Xia Mao; Dan Chen; Na Yin; Rolf Jessberger; Jordi C Ochando; Yaozhong Ding; Jonathan S Bromberg
Journal:  Immunity       Date:  2009-03-20       Impact factor: 31.745

8.  Affinity for self antigen selects Treg cells with distinct functional properties.

Authors:  Lena Wyss; Brian D Stadinski; Carolyn G King; Sonja Schallenberg; Nicholas I McCarthy; Jun Young Lee; Karsten Kretschmer; Luigi M Terracciano; Graham Anderson; Charles D Surh; Eric S Huseby; Ed Palmer
Journal:  Nat Immunol       Date:  2016-08-01       Impact factor: 25.606

9.  Intraclonal competition limits the fate determination of regulatory T cells in the thymus.

Authors:  Jhoanne L Bautista; Chan-Wang J Lio; Stephanie K Lathrop; Katherine Forbush; Yuqiong Liang; Jingqin Luo; Alexander Y Rudensky; Chyi-Song Hsieh
Journal:  Nat Immunol       Date:  2009-06       Impact factor: 25.606

10.  CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.

Authors:  Kristin V Tarbell; Sayuri Yamazaki; Kara Olson; Priscilla Toy; Ralph M Steinman
Journal:  J Exp Med       Date:  2004-06-07       Impact factor: 14.307

View more
  16 in total

1.  Position β57 of I-Ag7 controls early anti-insulin responses in NOD mice, linking an MHC susceptibility allele to type 1 diabetes onset.

Authors:  Louis Gioia; Marie Holt; Anne Costanzo; Siddhartha Sharma; Brian Abe; Lisa Kain; Maki Nakayama; Xiaoxiao Wan; Andrew Su; Clayton Mathews; Yi-Guang Chen; Emil Unanue; Luc Teyton
Journal:  Sci Immunol       Date:  2019-08-30

2.  CD4 T Cells Reactive to Hybrid Insulin Peptides Are Indicators of Disease Activity in the NOD Mouse.

Authors:  Rocky L Baker; Braxton L Jamison; Timothy A Wiles; Robin S Lindsay; Gene Barbour; Brenda Bradley; Thomas Delong; Rachel S Friedman; Maki Nakayama; Kathryn Haskins
Journal:  Diabetes       Date:  2018-07-05       Impact factor: 9.461

3.  The CD137 Ligand Is Important for Type 1 Diabetes Development but Dispensable for the Homeostasis of Disease-Suppressive CD137+ FOXP3+ Regulatory CD4 T Cells.

Authors:  Bardees M Foda; Ashley E Ciecko; David V Serreze; William M Ridgway; Aron M Geurts; Yi-Guang Chen
Journal:  J Immunol       Date:  2020-04-15       Impact factor: 5.422

4.  CD5 dynamically calibrates basal NF-κB signaling in T cells during thymic development and peripheral activation.

Authors:  Courtney A Matson; Seeyoung Choi; Ferenc Livak; Bin Zhao; Apratim Mitra; Paul E Love; Nevil J Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-08       Impact factor: 11.205

5.  A Critical Insulin TCR Contact Residue Selects High-Affinity and Pathogenic Insulin-Specific T Cells.

Authors:  Maria Bettini; Marissa A Scavuzzo; Baoyu Liu; Elizabeth Kolawole; Lin Guo; Brian D Evavold; Malgorzata Borowiak; Matthew L Bettini
Journal:  Diabetes       Date:  2019-12-13       Impact factor: 9.461

6.  Malt1 Protease Deficiency in Mice Disrupts Immune Homeostasis at Environmental Barriers and Drives Systemic T Cell-Mediated Autoimmunity.

Authors:  Kea Martin; Ratiba Touil; Yeter Kolb; Grozdan Cvijetic; Kiichi Murakami; Laura Israel; Fernanda Duraes; David Buffet; Anton Glück; Satoru Niwa; Marc Bigaud; Tobias Junt; Natasa Zamurovic; Philip Smith; Kathy D McCoy; Pamela S Ohashi; Frédéric Bornancin; Thomas Calzascia
Journal:  J Immunol       Date:  2019-10-28       Impact factor: 5.422

7.  CD5 levels define functionally heterogeneous populations of naïve human CD4+ T cells.

Authors:  Aditi Sood; Marie-Ève Lebel; Mengqi Dong; Marilaine Fournier; Suzanne J Vobecky; Élie Haddad; Jean-Sébastien Delisle; Judith N Mandl; Nienke Vrisekoop; Heather J Melichar
Journal:  Eur J Immunol       Date:  2021-03-19       Impact factor: 5.532

Review 8.  Function, Failure, and the Future Potential of Tregs in Type 1 Diabetes.

Authors:  Maria Bettini; Matthew L Bettini
Journal:  Diabetes       Date:  2021-05-20       Impact factor: 9.337

9.  A Role for Epitope Networking in Immunomodulation by Helminths.

Authors:  E Jane Homan; Robert D Bremel
Journal:  Front Immunol       Date:  2018-07-31       Impact factor: 7.561

Review 10.  Harnessing Mechanisms of Immune Tolerance to Improve Outcomes in Solid Organ Transplantation: A Review.

Authors:  Priscila Ferreira Slepicka; Mahboubeh Yazdanifar; Alice Bertaina
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.